Aprogen

Biotechnology company producing Biosimilars

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2000 groups66 employees language aprogen.com

Registered entities

Investor mix

5 investors on record; lead investors include Lindeman Asia Investment.

Investor typeCountShare
Venture capital120%
Private equity240%
Other / undisclosed240%
Coming soon